Behavioral Therapy for Early Psychosis
Trial Summary
What is the purpose of this trial?
This trial is testing a program that helps people with early psychosis learn new ways to manage their emotions and actions to reduce violent behavior.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Adapted Behavioral Intervention for early psychosis?
Research shows that cognitive-behavioral therapy for psychosis (CBTp) can be effective for persistent symptoms, especially when introduced during a stable phase of early psychosis. Additionally, cognitive adaptation training (CAT), a similar behavioral intervention, has shown improvements in functioning and symptoms in people with schizophrenia, suggesting potential benefits for early psychosis as well.12345
Is behavioral therapy for early psychosis safe for humans?
How is the Adapted Behavioral Intervention treatment for early psychosis different from other treatments?
Adapted Behavioral Intervention for early psychosis is unique because it focuses on behavioral therapy tailored to the individual's needs, potentially during a stable phase rather than an acute phase, which may improve long-term outcomes. This approach contrasts with traditional treatments that often involve medication or are introduced during acute episodes.2391011
Research Team
Stephanie Rolin, MD, MPH
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for young adults aged 16 to 30 who are receiving treatment for early psychosis at OnTrackNY clinics and can participate in research interviews. They must have a diagnosis within the schizophrenia spectrum, excluding affective psychoses, and be fluent in English.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week behavioral intervention to reduce violent behavior
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Adapted Behavioral Intervention (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Dr. Katrina Armstrong
Columbia University
Chief Executive Officer
MD from Johns Hopkins University, MS in Epidemiology from Harvard School of Public Health
Dr. Katrina Armstrong
Columbia University
Chief Medical Officer
MD from Harvard Medical School
National Institute of Mental Health (NIMH)
Collaborator
Dr. Joshua A. Gordon
National Institute of Mental Health (NIMH)
Chief Executive Officer since 2016
MD, PhD
Dr. Shelli Avenevoli
National Institute of Mental Health (NIMH)
Chief Medical Officer
PhD